Thus, men with loss of either functional estrogen receptor-α (ERα) or aromatase—the enzyme that generates estrogens from androgen precursors–exhibit metabolic derangements including increased visceral adiposity, insulin resistance, and reduced bone mineral density [1, 2]. Here, CYP19A1 is linked to Insulin resistance.